Ken Griffin Haemonetics Corp Call Options Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
Call Options
8 transactions
Others Institutions Holding HAE
# of Institutions
334Shares Held
52.2MCall Options Held
466KPut Options Held
128K-
Black Rock Inc. New York, NY5.96MShares$547 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.17MShares$474 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.44MShares$408 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.84MShares$352 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY3.83MShares$352 Million0.27% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $4.71B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...